home / stock / gnmsf / gnmsf short
Short Information | Genmab A/S Dkk (OTCMKTS:GNMSF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 8,159 |
Total Actual Volume | 12,552 |
Short Trends | |
---|---|
Cover Days | 10 |
Short Days | 7 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 408 |
Average Short Percentage | 38.54% |
Is there a GNMSF Short Squeeze or Breakout about to happen?
See the GNMSF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-07-2024 | $283.92 | $283.92 | $294.63 | $283.92 | 577 | 42 | 7.28% |
05-06-2024 | $285.91 | $296.59 | $296.59 | $285.91 | 255 | 155 | 60.78% |
05-03-2024 | $295 | $289.744 | $301.366 | $282.69 | 375 | 61 | 16.27% |
05-02-2024 | $287.03 | $276.47 | $287.03 | $272.95 | 160 | 129 | 80.62% |
04-30-2024 | $274.22 | $274.22 | $284.63 | $274.22 | 120 | 10 | 8.33% |
04-29-2024 | $285.43 | $272.05 | $285.43 | $272.05 | 497 | 145 | 29.18% |
04-25-2024 | $269.87 | $269.87 | $283.58 | $265.3 | 314 | 37 | 11.78% |
04-24-2024 | $279.24 | $279.6 | $290.4 | $275.55 | 1,217 | 547 | 44.95% |
04-23-2024 | $280.41 | $290.34 | $294.54 | $279.36 | 343 | 184 | 53.64% |
04-22-2024 | $279.76 | $289.67 | $290.528 | $279.76 | 5,321 | 5,228 | 98.25% |
04-19-2024 | $287.06 | $284.55 | $288.3 | $283.3 | 241 | 171 | 70.95% |
04-18-2024 | $281.08 | $290.38 | $290.38 | $279.82 | 217 | 77 | 35.48% |
04-17-2024 | $282.2 | $281.02 | $292.85 | $278.65 | 212 | 13 | 6.13% |
04-16-2024 | $295.94 | $285.11 | $295.94 | $285.11 | 417 | 156 | 37.41% |
04-15-2024 | $295.59 | $282.004 | $295.59 | $278.46 | 206 | 54 | 26.21% |
04-12-2024 | $292.51 | $291.12 | $297.46 | $290.92 | 299 | 14 | 4.68% |
04-11-2024 | $306.17 | $298.164 | $306.17 | $294.75 | 766 | 741 | 96.74% |
04-10-2024 | $289.77 | $297.74 | $302.348 | $289.77 | 156 | 4 | 2.56% |
04-09-2024 | $292.21 | $296 | $300.9 | $292.21 | 364 | 8 | 2.2% |
04-08-2024 | $292.79 | $291.92 | $303.71 | $291.92 | 495 | 383 | 77.37% |
News, Short Squeeze, Breakout and More Instantly...
Genmab A/S Dkk Company Name:
GNMSF Stock Symbol:
OTCMKTS Market:
May 2, 2024 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2024 Highlights The U.S. Food and Drug Administration (U.S. FDA) granted Priority Review for the supplemental Biologics License Application (sBLA) for EPKINLY ® (epcorita...
Company Announcement Full approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapy TIVDAK is the first antibody-drug conjugate in this patient population to have positive overall survival data COPENHAGEN, Denmark;...
Company Announcement COPENHAGEN, Denmark; February 14, 2024 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2023. Below is a summary of business progress in 2023, financial performance for the year and the financial outlook for...